Throughout our project's development, we have iterated through each of the stages of the engineering cycle, in order to ensure an efficient and robust engineering process. Here we describe our usage of the design-build-test-learn cycle in the different aspects of the project.
Engineer in foreign chemotaxis under Nd upregulation =>
No build for WT characterisation
We were interested in chemotaxis, and therefore had to decide on a motility assay and optimise for M. extorquens. We chose a qualititive assay that gives a robust binary result within an hour of inoculation, and uses small plates such that it does not waste resources.
Unfortunately, we got no positive results, even from positive control. Therefore, we moved on to a protocol that i) can be troubleshot more easily, and ii) better matches the setup for our proof of concept.
The new design facilitates taxis over the course of the growth timeframe, and also allows a quantitative measurement of the cells’ propensity to move towards the chemoattractants.
We see colonies mostly ascribing to the third option – no motility. This was highly concerning, as it suggested that the strain of M. extorquens we had had been domesticated such that it had lost motility. We knew we needed to somehow reintroduce it, but that using genetic engineering would be a largely blind process.
We opted to perform a series of successive swim plates, each time taking bacteria from the farthest point that it grew from inoculation, and reinoculating with that.
This directed evolution was repeated until we saw sufficient motility to be characterisable. We grew up two motile colonies, made glycerol stocks of them and named them ‘Mex mot A’; and ‘Mex mot B’. We used Mex mot A for all future experimentation and transformation.
We reattempted the assay in the previous cycle with our Mex mot A strain.
We successfully observed negative results for the E. coli chemoattractants. This gave us a choice of chemoattractants, so we were able to pick one that is:
We chose Tar for aspartate sensing, because:
For Nd regulation, we inserted the intergenic region upstream of M. extorquens' xoxF1, which is characterised as being robustly upregulated in lanthanides (La3+, Ce3+).
Using aspatate in plug, perform Ex (2) from previous cycle with:
We saw some limited movement towards Asp in the transformant and not in the untransformed Mex mot A strain at 0.2% w/v agar.
=> Successful endowment of aspartate taxis in Nd-supplemented media.
Therefore, we planned to engineer in LutH and LanM under inducible, titratable regulation, to test for optimal expression levels.
With our promoter choice, even leaky expression of lutH was observed to be lethal to cells.
This assay measures the reduction in Nd concentration, which is in theory more sensitive to conditions where the majority of Nd is uptaken.
This assay measures the uptake into cells directly, and allows standardisation by cell density. In theory it is more sensitive to conditions where cell uptake of Nd is limited.
Limited use of ICP-MS caused us to decide to run the assay 2) only.
We found WT uptake was extremely efficient at the concentrations of Nd that we used. Therefore, we did not redesign the expression construct for weaker expression of LutH, because it was no longer considered an effective optimisation. This choice was supported by our model by this stage.
lanM did result in increased uptake per cell, which supports our idea of using it for neodymium sequestration. Nevertheless, it was not deemed necessary to optimise the design of lanM for uptake, because the WT was sufficiently efficient.
We decided to go with viability plates, because we expected our results to be spread across several magnitudes of neodymium concentrations.
Inconsistent results across similar experiments cast doubt on results, but initial analysis is promising. More repeats are required for a robust claim of success, but LanM does appear to reduce stress manyfold, in line with predictions from our model.
An enzymatic assay for [Nd] quantification. Details of assay chemistry on Protocols / Contribution pages.
Here, we focus on XoxF purification.
XoxF = approx. 65 kDa, 4 Cys-S-S-Cys, periplasmic, dimerizes
Initial expression system: E. coli BL21, pET-28a(+)
Purify with Ni2+ column
Assay failed to show any activity.
SDS-PAGE showed protein was insoluble. We determined that we needed to change conditions to promote solubility.
Retry using cell lysate directly, supported by literature.
Same system
No activity
Protein is insoluble, at least by lysis.
Retry with 4-fold reduced induction & in vivo assay
Reduce [IPTG] from 1 mM to 0.25 mM
Tested both, no activity
Expression system is poor; pET-28a(+) does not facilitate the biophysical properties of XoxF
Resolubilise and refold protein
Extract inclusion bodies, resolubilise and refold them. Limitations with available lab equipment reduced the viability of the refolding step, as we had to perform dilution instead of dialysis.
Protein resolubilisation was succesful, but no activity with refolded protein
In hindsight, had we had more experience with protein work across the team, we would have recognised that the expression system we used was inappropriate for a protein with the biophysical characteristics of XoxF, and we would have performed an existing protocol in the literature for purification
Transition to an M. extorquens-based expression system, as detailed as giving soluble protein in the literature
Limited by time constraints of iGEM season
The bacterial strains used are those generated in previous cycles, but the setup still requires design. A particular issue was the collection of samples, because the soft agar cannot be excised effectively – the agar reforms around a blade.
In order to collect samples reliably, we designed a simple 3D-printed ‘cookie cutter’, detailed on the protocols page. The cutter is stabbed into the plate with gridlines pre-drawn, and the soft agar is pipetted up.
This produces robust, reliable, reproducible results.
The samples can then be solubilised with a chaotrope, and sonicated to lyse. Storage at -20 °C is good to prevent cell regrowth.
Run assay, collect samples. Samples quantified by:
We saw promising results!
We analysed different strains/conditions to assess the impact of our genetic components. See results for discussion.